期刊文献+

ERβ1影响乳腺癌上皮间质转化和侵袭迁移的初步实验研究 被引量:4

ERβ1 inhibits epithelial-mesenchymal transition,invasion and migration of breast cancer cells
原文传递
导出
摘要 目的探讨雌激素受体β1(estrogen receptorβ1,ERβ1)能否通过调控E-钙粘蛋白(E-cadherin,E-cad)的表达影响乳腺癌细胞上皮间质转化(epithelial-mesenchymal transition,EMT)的发生,ERβ1在乳腺癌细胞侵袭迁移中的作用。方法通过脂质体法将ERβ1真核表达质粒和特异性siRNA-ERβ1转染至人乳腺癌MDA-MB-231细胞中,干预细胞中ERβ1的表达,采用RT-PCR、Western blot法分别在mRNA和蛋白水平观察干预ERβ1后对E-cad表达的影响,进行体外侵袭迁移实验,观察干预细胞中ERβ1的表达对乳腺癌细胞恶性生物学行为的改变。结果过表达ERβ1后,ERβ1及E-cad在mRNA[(0.823±0.028)vs(0.554±0.044),P=0.025;(0.944±0.04)vs(0.724±0.28),P=0.026]和蛋白[(1.331±0.019)vs(0.463±0.019),P=0.001;(1.428±0.005)vs(0.500±0.010),P<0.01]水平均表达升高,侵袭[(45.8±7.4)vs(70.4±13.3),P=0.039]迁移[(75.6±8.8)vs(111.8±15.1),P=0.021]力显著下降,干扰ERβ1表达后,ERβ1及E-cad在mRNA[(0.314±0.029)vs(0.554±0.044),P=0.030;(0.444±0.042)vs(0.724±0.28),P=0.001]和蛋白[(0.353±0.017)vs(0.463±0.019),P=0.032;(0.397±0.034)vs(0.500±0.010),P=0.024]水平均表达降低,侵袭[(193±22.6)vs(70.4±13.3),P<0.05]迁移[(264.2±53.7)vs(111.8±15.1),P=0.002]力显著增强。结论ERβ1可能参与乳腺癌的EMT过程,进而影响乳腺癌细胞的侵袭转移能力。 Objective To investigate the role of estrogen receptor β1 (ERβ1) in epithelial-mesenchymal transition (EMT) of breast cancer cells by regulating the expression of E-cadherin (E-cad), and to explore the effects of ERβ1 on the invasion and migration of breast cancer cells.Methods The recombinant eukaryotic vector containing ERβ1 cDNA or specific siRNA targeting ERβ1 was transfected to human breast cancer cells MDA-MB-231 to interfere the expression of ERβ1. RT-PCR and Western blotting were used to detect the expression of ERβ1 and E-cad on mRNA and protein levels. Moreover, invasion and migration assays in vitro were applied to assess the influence of ERβ1 expression interference on malignant biological behavior of breast cancer.Results When ERβ1 was over-expressed, ERβ1 and E-cad showed increased expression at mRNA (0.823±0.028 vs 0.554±0.044, P=0.025; 0.944±0.04 vs 0.724±0.28, P=0.026) and protein (1.331±0.019 vs 0.463±0.019, P=0.001; 1.428±0.005 vs 0.500±0.010, P〈0.01) levels, and the cells showed decrease of invasion (45.8±7.4 vs 70.4±13.3, P=0.039) and migration (75.6±8.8 vs 111.8±15.1, P=0.021) abilities. When ERβ1 was down-regulated, ERβ1 and E-cad showed decreased expression at mRNA (0.314±0.029 vs 0.554±0.044, P=0.030; 0.444±0.042 vs 0.724±0.28, P=0.001) and protein (0.353±0.017 vs 0.463±0.019, P=0.032; 0.397±0.034 vs 0.500±0.010, P=0.024) levels, and the cells showed increase of invasion (193±22.6 vs 70.4±13.3, P〈0.05) and migration (264.2±53.7 vs 111.8±15.1, P=0.002) abilities.Conclusion ERβ1 may participate in EMT of breast cancer and further influence the invasion and metastasis of breast cancer.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2014年第4期317-320,共4页 Journal of Third Military Medical University
基金 国家自然科学基金青年基金(81102031)~~
关键词 乳腺肿瘤 雌激素受体β1 E-钙粘蛋白 上皮间质转化 细胞迁移 breast neoplasms estrogen receptor beta E-cadherin epithelial-mesenchymal transition cell migration
  • 相关文献

参考文献3

二级参考文献49

  • 1陈莉,姜军,杨新华,范林军,陈显春.乳腺癌端粒酶逆转录酶mRNA和BRCA1蛋白表达及其相互关系[J].中国普外基础与临床杂志,2006,13(4):434-436. 被引量:3
  • 2Hall JM,Couse JF,Korach KS.The multifaceted mechanisms of estradiol and estrogen receptor signaling.J Biol Chem,2001,276:36869-36872.
  • 3Nilsson S,Gustafsson JA.Estrogen receptor action.Crit.Rev Eukaryot Gene Expr,2002,12:237-257.
  • 4Kuiper GG,Enmark E,Pelto-Huikko M,et al.Cloning of a novel receptor expressed in rat prostate and ovary.Proc Natl Acad Sci USA,1996,93:5925-5930.
  • 5Kelley ST,Thackray VG.Phylogenetic analyses reveal ancient duplication of estrogen receptor isoforms.J Mol Evol,1999,49:609-614.
  • 6Lazennec G.Estrogen receptor beta:a possible tumor suppressor involved in ovarian carcinogenesis.Cancer Lett,2006,231:151-157.
  • 7Mosselman S,Polman J,Dijkema R.ER2β:identification and characterization of a novel human estrogen receptor.FEBS Lett,1996,392:49-53.
  • 8Gustafsson JA,Warner M.Estrogen receptor beta in the breast;role in estrogen responsiveness and development of breast cancer.J Steroid Biochem Mol Biol,2000,74:245-248.
  • 9Honma N,Horii R,Iwase T,et al.Clinical importance of estrogen receptor-β evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.J Clin Oncol,2008,26:3727-3734.
  • 10Chen L,Qiu JH,Yang XH,et al.Identification of a novel estrogen receptor b1 binding partner,inhibitor of differentiation1,and role of ERb1 in human breast cancer cells.Cancer Lett,2009,278:210-219.

共引文献2

同被引文献75

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部